2020
DOI: 10.1016/j.jacc.2019.11.062
|View full text |Cite
|
Sign up to set email alerts
|

Biological Versus Chronological Aging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
249
0
18

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 266 publications
(271 citation statements)
references
References 113 publications
4
249
0
18
Order By: Relevance
“…To date, no standardized biomarkers of physiologic ageing are currently available. We, therefore, believe that our voice analysis with machine learning would provide a novel and advanced tool possibly helpful for quantifying the individual “biological” age of a single subject [ 81 , 82 ]. The objective voice analysis would also allow to better discriminate and monitor processes of physiological as well as pathological ageing.…”
Section: Discussionmentioning
confidence: 99%
“…To date, no standardized biomarkers of physiologic ageing are currently available. We, therefore, believe that our voice analysis with machine learning would provide a novel and advanced tool possibly helpful for quantifying the individual “biological” age of a single subject [ 81 , 82 ]. The objective voice analysis would also allow to better discriminate and monitor processes of physiological as well as pathological ageing.…”
Section: Discussionmentioning
confidence: 99%
“…The concept of biological aging comes from the fact that individuals do not age at the same pace. In particular, vascular aging involves arterial degeneration and hardening that impairs vascular function and ultimately causes end organ damage 27 . Concerning biomarkers of biological vascular aging, the most common arterial stiffness measure is pulse wave velocity (PWV), in our case the PPG waves, the velocity at which the blood pressure wave moves along the arterial tree.…”
Section: Discussionmentioning
confidence: 99%
“…Atherosclerosis is a major contributor to adverse events and deaths from cardiovascular disease, and its onset and clinical manifestation are highly variable between normally-aging individuals [ 29 ]. Studying diseases that drastically accelerate atherogenesis in the absence of traditional cardiovascular risk factors, such as HGPS, may therefore help to identify unknown factors that speed up this process [ 30 ].…”
Section: Discussionmentioning
confidence: 99%